1. Home
  2. RRGB vs CTMX Comparison

RRGB vs CTMX Comparison

Compare RRGB & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Robin Gourmet Burgers Inc.

RRGB

Red Robin Gourmet Burgers Inc.

HOLD

Current Price

$4.03

Market Cap

88.7M

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.16

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRGB
CTMX
Founded
1969
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.7M
596.2M
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
RRGB
CTMX
Price
$4.03
$4.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$11.00
$6.50
AVG Volume (30 Days)
202.4K
2.1M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$1,226,409,000.00
$113,631,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.49
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.40
52 Week High
$7.89
$4.62

Technical Indicators

Market Signals
Indicator
RRGB
CTMX
Relative Strength Index (RSI) 37.93 57.36
Support Level $3.85 $3.78
Resistance Level $4.05 $4.20
Average True Range (ATR) 0.18 0.24
MACD 0.07 -0.02
Stochastic Oscillator 33.80 73.88

Price Performance

Historical Comparison
RRGB
CTMX

About RRGB Red Robin Gourmet Burgers Inc.

Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: